Considerations in the management of steroid-dependent Crohn’s disease
- 30 September 2003
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 125 (3), 906-910
- https://doi.org/10.1016/s0016-5085(03)01129-6
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Corticosteroids in Crohn's diseaseAmerican Journal of Gastroenterology, 2002
- The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based studyGastroenterology, 2001
- The Long-term Benefit of Surgery on Health-Related Quality of Life in Patients With Inflammatory Bowel DiseaseArchives of Surgery, 2001
- Medical Therapy To Reduce Postoperative Crohn's Disease RecurrenceAmerican Journal of Gastroenterology, 2000
- Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohortGastroenterology, 1999
- Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study.Gut, 1996
- Mesalamine in Crohn's disease with steroid-induced remission: Effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Therapeutiques des Affections Inflammatoires DigestivesGastroenterology, 1996
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 1996
- Effects of cigarette smoking on the long-term course of Crohn's diseaseGastroenterology, 1996
- Frequency of glucocorticoid resistance and dependency in Crohn's disease.Gut, 1994